Patents by Inventor Chuiliang YU

Chuiliang YU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250120910
    Abstract: A pharmaceutical composition, a preparation method therefor and an application thereof. The pharmaceutical composition comprises the following components: a compound represented by formula I, hydroxypropyl methyl cellulose, benzalkonium chloride, and a pH regulator. The pharmaceutical composition can be used for preparing drugs for preventing or treating cataracts. The pharmaceutical composition has excellent stability in respect of exposure to light and to high temperatures, can be stored at room temperature, is convenient for patients to use, has pH and osmotic pressure close to those in the intraocular environment, is uniform in particle size distribution, and thus can give the patients good comfort.
    Type: Application
    Filed: August 17, 2022
    Publication date: April 17, 2025
    Inventors: Yandong Wang, Yingxue Su, Chen Cao, Sheng'an Zhou, Yaping Xue, Meirong Wu, Chuiliang Yu
  • Publication number: 20240374615
    Abstract: An application of a steroid compound in the preparation of a drug for preventing and/or treating eye floaters. The steroid compound can have good therapeutic, alleviative, and preventive effects on eye floaters, can alleviate and/or cure eye floaters to a great extent, and can improve visual clarity.
    Type: Application
    Filed: August 17, 2022
    Publication date: November 14, 2024
    Inventors: Yandong Wang, Yingxue Su, Chen Cao, Meirong Wu, Yaping Xue, Chuiliang Yu
  • Publication number: 20240352058
    Abstract: A steroidal compound, a preparation method therefor and an application thereof. On one hand, provided are a compound represented by formula I, a preparation method therefor, and an application thereof in a method for separating and purifying lanosterol; on the other hand, provided is the method for separating and purifying lanosterol. The method is simple to operate, stable in process, high in productivity and low in cost, and the obtained lanosterol has high purity and can meet medical application thereof.
    Type: Application
    Filed: August 30, 2022
    Publication date: October 24, 2024
    Inventors: Chuiliang Yu, Xiaolin Li, Yandong Wang, Xiaobing Lan, Fei Hao, Yingxue Su, Haiying He, Meirong Wu
  • Publication number: 20240315966
    Abstract: A composition containing loxoprofen sodium. The composition comprises loxoprofen sodium, sodium hyaluronate and polysorbate 80, wherein the molecular weight of sodium hyaluronate is 0.8×106?1.6×106. The composition has good stability and a long shelf life and is convenient to use.
    Type: Application
    Filed: July 8, 2022
    Publication date: September 26, 2024
    Inventors: Shengan Zhou, Chuiliang Yu, Yandong Wang, Ximing Feng, Yaxiong Li, Meirong Wu
  • Publication number: 20240315995
    Abstract: The present invention relates to an application of loxoprofen sodium or a composition containing loxoprofen sodium in the preparation of a drug for preventing and/or treating the dry eye disease.
    Type: Application
    Filed: July 8, 2022
    Publication date: September 26, 2024
    Inventors: Chiyong Liang, Yandong Wang, Chuiliang Yu, Liang Li, Yaping Xue, Meirong Wu
  • Patent number: 10894038
    Abstract: Provided are certain URAT1 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
    Type: Grant
    Filed: December 26, 2016
    Date of Patent: January 19, 2021
    Assignees: SHANGHAI FOCHON PHARMACEUTICAL CO. LTD., FOCHON PHARMACEUTICALS, LTD.
    Inventors: Tongshuang Li, Xingdong Zhao, Chuiliang Yu, Haohan Tan, Xianlong Wang, Rui Tan, Bin Liu, Weipeng Zhang, Huajie Zhang, Qihong Liu, Zuwen Zhou, Zhifu Li, Yue Rong, Jing Sun, Weibo Wang
  • Publication number: 20200113876
    Abstract: Provided are certain URAT1 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
    Type: Application
    Filed: December 26, 2016
    Publication date: April 16, 2020
    Inventors: Tonshuang LI, Xingdong ZHAO, Chuiliang YU, Haohan TAN, Xianlong WANG, Rui TAN, BIN LIU, Weipeng ZHANG, Huajie ZHANG, Qihong LIU, Zuwen ZHOU, Zhifu LI, Yue RONG, Jing SUN, Weibo WANG
  • Patent number: 10328060
    Abstract: Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
    Type: Grant
    Filed: November 1, 2015
    Date of Patent: June 25, 2019
    Assignees: SHANGHAI FOCHON PHARMACEUTICAL CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES, CHONGQING FOCHON PHARMACEUTICAL CO., LTD.
    Inventors: Xingdong Zhao, Jian Ding, Linghua Meng, Meiyu Geng, Tongshuang Li, Zuwen Zhou, Ling Chen, Qihong Liu, Xianlong Wang, Lijun Yang, Yue Rong, Rui Tan, Chuiliang Yu, Lihua Jiang, Yanxin Liu, Li Linghu, Jing Sun, Weibo Wang
  • Publication number: 20180036293
    Abstract: Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
    Type: Application
    Filed: November 1, 2015
    Publication date: February 8, 2018
    Applicants: Shanghai Fochon Pharmaceutical Co., Ltd., Shanghai Institute of Materia Medica Chinese Academy of Sciences, ChongQing Fochon Pharmaceutical Co., Ltd.
    Inventors: Xingdong ZHAO, Jian DING, Linghua MENG, Meiyu GENG, Tongshuang LI, Zuwen ZHOU, Ling CHEN, Qihong LIU, Xianlong WANG, Lijun YANG, Yue RONG, Rui TAN, Chuiliang YU, Lihua JIANG, Yanxin LIU, Li LINGHU, Jing SUN, Weibo WANG